GPX4 and osteoarthritis: In bone marrow mesenchymal stem cells, NRF2/GPX4 activation enhances osteogenic capacity under oxidative stress [37], while in chondrocytes, SIRT1/NRF2/HO-1 signaling mitigates osteoarthritis progression by suppressing ferroptosis [36].